FR09C0047I2 - Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation - Google Patents

Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Info

Publication number
FR09C0047I2
FR09C0047I2 FR09C0047C FR09C0047C FR09C0047I2 FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2 FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 C FR09C0047 C FR 09C0047C FR 09C0047 I2 FR09C0047 I2 FR 09C0047I2
Authority
FR
France
Prior art keywords
carbonhydrates
immunogenic
soluble
activated
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR09C0047C
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Found For T
Original Assignee
Henry M Jackson Found For T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/408,717 external-priority patent/US5651971A/en
Priority claimed from PCT/US1996/004013 external-priority patent/WO1996029094A1/en
Publication of FR09C0047I1 publication Critical patent/FR09C0047I1/fr
Application filed by Henry M Jackson Found For T filed Critical Henry M Jackson Found For T
Application granted granted Critical
Publication of FR09C0047I2 publication Critical patent/FR09C0047I2/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
FR09C0047C 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation Active FR09C0047I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/408,717 US5651971A (en) 1993-09-22 1995-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US48266195A 1995-06-07 1995-06-07
PCT/US1996/004013 WO1996029094A1 (en) 1995-03-22 1996-03-22 Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents

Publications (2)

Publication Number Publication Date
FR09C0047I1 FR09C0047I1 (https=) 2009-06-11
FR09C0047I2 true FR09C0047I2 (fr) 2017-03-17

Family

ID=41360971

Family Applications (1)

Application Number Title Priority Date Filing Date
FR09C0047C Active FR09C0047I2 (fr) 1995-03-22 2009-09-24 Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation

Country Status (5)

Country Link
JP (1) JP5594612B2 (https=)
KR (1) KR100417183B1 (https=)
DE (2) DE122009000055I1 (https=)
FR (1) FR09C0047I2 (https=)
NL (2) NL300414I1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2836153C (en) * 2009-12-17 2016-06-21 Fina Biosolutions, Llc Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE343210B (https=) * 1967-12-20 1972-03-06 Pharmacia Ab
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
DE3541186A1 (de) * 1985-11-21 1987-05-27 Boehringer Mannheim Gmbh Wasserloesliche, stabilisierte peroxidasederivate, verfahren zu ihrer herstellung und verwendung zur bestimmung von wasserstoffperoxid
MY104520A (en) * 1989-11-15 1994-04-30 Novartis Ag Polymyxin conjugates.
DE69231663T2 (de) * 1991-03-12 2001-08-23 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Polysaccharid-protein-konjugate
ES2204900T3 (es) * 1992-02-11 2004-05-01 Henry M. Jackson Foundation For The Advancement Of Military Medicine Estructura inmuinogena de doble vector.
WO1994013697A1 (en) * 1992-12-07 1994-06-23 Magainin Pharmaceuticals, Inc. Treatment of septic shock with conjugated biologically active peptides

Also Published As

Publication number Publication date
DE122009000056I1 (de) 2010-01-28
KR100417183B1 (ko) 2004-05-31
NL300413I1 (nl) 2009-12-01
JP2012116850A (ja) 2012-06-21
DE122009000055I1 (de) 2009-12-31
FR09C0047I1 (https=) 2009-06-11
JP5594612B2 (ja) 2014-09-24
KR19980703201A (ko) 1998-10-15
NL300414I1 (nl) 2009-12-01

Similar Documents

Publication Publication Date Title
IL113817A0 (en) Polynucleotide vaccine for papillomavirus pharmaceutical compositions containing it and a method for its use
FI956261L (fi) Jodattu neurokoetin monoamiinin takaisinottokohtien kartoittamiseksi
FR2817912B1 (fr) Reducteur reprenant les efforts axiaux generes par la soufflante d'un turboreacteur
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
EP0753296A3 (en) Oral formulations containing S (+) - ibuprofen
EP0372466A3 (en) 2-amino-4 or 5-methoxycyclohexyl amides useful as analgesics
HUP0004853A3 (en) Hepatitis c inhibitor peptides, process for preparation thereof, pharmaceutical compositions comprising thereof, their use and their intermediates
ATE515569T1 (de) Peptidnucleinsäuren
ES2181799T3 (es) Conjugados de acidos peptido nucleicos.
AU4741997A (en) Oral administration of chicken yolk antibodies to treat disease
NO975555L (no) Vaksine omfattende polysakkaridangiten-proteinbærer-konjugat og fritt bærerprotein
FI943316A7 (fi) Farmaseuttiset koostumukset, joissa on nifedipiiniä ja menetelmä sen v almistamiseksi
FI963786L (fi) Uusia 1,4-disubstituoituja piperidiinijohdannaisia, jotka ovat käyttökelpoisia glutamaattireseptoriin vaikuttavina lääkeaineina
FI970247L (fi) Farmaseuttisia koostumuksia, jotka sisältävät kimeerisen TNF:ää sitovan proteiinin
FR09C0047I2 (fr) Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation
IL133752A0 (en) Process for the preparation of mometasone furoate
FR2645878B1 (fr) Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
MX9603124A (es) Vacuna contra el virus de la enfermedad de newcastle benigna.
PT84399B (en) Process for the preparation of pharmaceutical compositions containing sodium 2-(2,6-dichloroanilino) phenylacetate
FI974435L (fi) Menetelmä 2,4-diklooripyridiinien muuttamiseksi 2-aryylioksi-4-klooripyridiineiksi
HUP9802568A3 (en) Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists and pharmaceutical compositions containing them
NO981070D0 (no) Benzotiofener-2-karboksamider-S,S-dioksider anvendt for forhindring av begroing
FR2693722B1 (fr) Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
RU97120940A (ru) Пептид, обладающий иммуномодулирующей активностью, и препарат на его основе
AU5474190A (en) Canine corona virus vaccine